LETTER

Identification of novel modulators of mitochondrial function by a genome-wide RNAi screen in Drosophila melanogaster

    • 1 Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139, USA;
    • 2 Diabetes and Metabolism Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139, USA;
    • 3 NIBR Patents, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139, USA
Published November 27, 2007. Vol 18 Issue 1, pp. 123-136. https://doi.org/10.1101/gr.6940108
Download PDF Please log-in to or register for your personal account in order to access PDF Cite Article Permissions Share
cover of Genome Research Vol 36 Issue 4
Current Issue:

Abstract

Mitochondrial dysfunction is associated with many human diseases. There has not been a systematic genetic approach for identifying regulators of basal mitochondrial biogenesis and function in higher eukaryotes. We performed a genome-wide RNA interference (RNAi) screen in Drosophila cells using mitochondrial Citrate synthase (CS) activity as the primary readout. We screened 13,071 dsRNAs and identified 152 genes that modulate CS activity. These modulators are involved in a wide range of biological processes and pathways including mitochondrial-related functions, transcriptional and translational regulation, and signaling pathways. Selected hits among the 152 genes were further analyzed for their effect on mitochondrial CS activity in transgenic flies or fly mutants. We confirmed a number of gene hits including HDAC6, Rpd3(HDAC1), CG3249, vimar, Src42A, klumpfuss, barren, and smt3 which exert effects on mitochondrial CS activities in vivo, demonstrating the value of Drosophila genome-wide RNAi screens for identifying genes and pathways that modulate mitochondrial function.

Loading
Loading
Back to top